Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-09

FDA Approved: XYWAV — Supplemental Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for XYWAV, the calcium, magnesium, potassium, and sodium oxybates product from Jazz Pharmaceuticals. The approval pertai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)

Snippet

SUPPL AP for XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)